0001209191-23-045263.txt : 20230810
0001209191-23-045263.hdr.sgml : 20230810
20230810084108
ACCESSION NUMBER: 0001209191-23-045263
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230808
FILED AS OF DATE: 20230810
DATE AS OF CHANGE: 20230810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamothe Jeffrey G.
CENTRAL INDEX KEY: 0001679967
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 231157367
MAIL ADDRESS:
STREET 1: 2401 4TH AVENUE
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-08
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001679967
Lamothe Jeffrey G.
C/O APTEVO THERAPEUTICS INC.
2401 4TH AVENUE, SUITE 1050
SEATTLE
WA
98121
0
1
0
0
EVP, COO
0
Common Stock
2023-08-08
4
M
0
11979
A
24671
D
Common Stock
2023-08-08
4
M
0
1833
A
26504
D
Restricted Stock Unit
2023-08-08
4
M
0
11979
0.00
D
Common Stock
11979
11979
D
Restricted Stock Unit
2023-08-08
4
M
0
1833
0.00
D
Common Stock
1833
3667
D
Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
On August 9, 2022, the reporting person was granted 23,958 RSUs, vesting in two approximately equal installments beginning on August 8, 2023.
On August 9, 2022, the reporting person was granted 5,500 RSUs, vesting in three approximately equal installments beginning on August 8, 2023.
/s/ SoYoung Kwon, Attorney-in-Fact
2023-08-10